FDA Okays Pfizer Antibody-Drug Conjugate for Pediatric ALL FDA Okays Pfizer Antibody-Drug Conjugate for Pediatric ALL

A complete remission rate of 42% led to the approval of inotuzumab ozogamicin for children.Medscape Medical News

Source: Medscape Hematology-Oncology Headlines - March 7, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news